Symptomatic intraventricular cysticerci are said to respond poorly to the anticestodial agent praziquantel. A case is reported of rapid regression of a large cyst of the fourth ventricle after oral praziquantel, avoiding the need for surgery.
Before 1979, treatment for neurocysticercosis involved excision of symptomatic cysts and shunting of obstructive hydrocephalus.' More recently praziquantel has proved useful in parenchymal and basal/meningeal neurocysticercosis, where reduction in cyst size and often complete disappearance of cysts have been noted.23 In contrast, the response of intraventricular cysts to praziquantel therapy has been disappointing, leading to the recommendation that these cysts should be treated surgically and not with praziquantel. 4 Case report A 36 year old Asian female presented with a short history of intermittent diplopia and blurring of vision. She also complained of morning headache, nausea, vomiting and occasional unsteadiness of gait. There was no history of epilepsy. Her visual fields and acuity were normal but diplopia was present on upgaze and there was early bilateral papilloedema. A mild degree of disequilibrium was noted.
Computerised series6 and 26-3% died in another series. 7 The poor results were largely attributed to secondary inflammatory changes leading to difficult dissection.
In comparison, treatment with praziquantel is safe, although an inflammatory response similar to the Jarisch Herxheimer reaction has been described. 8 Simultaneous administration of corticosteroids prevents or attenuates this reaction.'
Our findings of rapid clinical and radiological response to oral praziquantel contrast with the findings of Vasconcelos et al' who reported no change in the appearance of fourth ventricular cysts in their series of four patients receiving oral praziquantel 50 mg/kg/ day without steroid cover. Our patient received prednisolone in addition to praziquantel. Steroids alone do not appear to have any effect on the size of cysticercosis cysts. 9 Our experience suggests that a trial of oral praziquantel is worthwhile in neurocysticercosis even for intraventricular cysts, in the hope of avoiding the morbidity and mortality associated with posterior fossa surgery. 
